Clinical trialRSSYesterday
Scientists tested a new pill called VQ-101 that can enter the brain and increase levels of a protective protein in people with Parkinson's disease. In early testing, the drug worked in patients both with and without a specific genetic change (GBA mutation). This is an important first step toward potentially helping different groups of Parkinson's patients.
WHY IT MATTERSThis is one of the first oral drugs shown to cross the blood-brain barrier and activate neuroprotective pathways in genetically diverse Parkinson's patients, potentially expanding treatment options beyond GBA-mutation carriers.
ResearchRSSYesterday
A large study found that children with Duchenne muscular dystrophy (DMD) who started taking corticosteroids—a type of anti-inflammatory medicine—earlier in life had better muscle strength and movement than children who started the medicine about a year later. This shows that starting treatment as soon as possible after diagnosis helps preserve how well kids can walk, run, and use their muscles.
WHY IT MATTERSIf you have a young child with DMD, this research provides strong evidence to discuss with your doctor about starting corticosteroid treatment immediately after diagnosis rather than waiting, as earlier treatment may significantly slow muscle weakness.
NewsRSSYesterday
A father shares a personal story about visiting his 20-year-old son and balancing pride with concern about his health. The article appears to be a personal reflection from a parent in the hemophilia community, though the full content is not available in this excerpt.
WHY IT MATTERSParents of children with hemophilia often navigate complex emotions about their child's condition and independence — this personal account may help other families feel less alone in similar situations.
NewsRSSYesterday
A person with SMA (spinal muscular atrophy) experienced a serious fall onto concrete while their nurse was helping them get dressed, resulting in intense knee pain. The article discusses how this unexpected injury was a frightening experience for someone already managing a complex rare disease. The post appears to be a personal account about dealing with this new complication.
WHY IT MATTERSPeople with SMA have increased fall risk and fragility due to muscle weakness, making even routine activities like being dressed potentially dangerous — this story highlights a real safety concern for SMA patients and caregivers.
NewsRSSYesterday
This is a personal story about a man with ALS (a disease that affects nerve cells and causes muscle weakness) and how his dog Comet has become an important part of his life. As Todd's mobility has decreased over time, he's found creative ways to spend time with Comet, like riding on a scooter with the dog. The story shows how pets can bring joy and connection to people living with serious illnesses.
WHY IT MATTERSFor people with ALS and their caregivers, this story demonstrates how adaptive strategies and pet companionship can maintain quality of life and emotional well-being as the disease progresses.
ResearchPUBMED2 days ago
Scientists are studying a new type of medicine made from circular RNA, which is RNA shaped like a circle instead of a line. Because of their circular shape, these medicines may stay in the body longer and work better than current RNA medicines. Researchers are testing these circular RNA medicines to treat cancer, immune system diseases, and rare diseases.
WHY IT MATTERSCircular RNA therapeutics could eventually offer longer-lasting treatments for rare diseases with fewer doses needed, but patients should know that claims about safety and effectiveness vary depending on how the medicine is made—there's no one-size-fits-all answer yet.
NewsRSS2 days ago
A patient with AATD (a rare lung disease caused by low levels of a protective protein) shares her personal experiences with complementary and alternative medicine approaches. She discusses how nontraditional treatments have fit into her overall care plan alongside standard medical treatment. The article reflects one patient's perspective on combining different types of medicine to manage her condition.
WHY IT MATTERSPatients with AATD can learn from one person's real-world experience balancing conventional treatment with complementary approaches, which may help inform their own conversations with their healthcare team about what options exist.
ResearchRSS2 days ago
Scientists found that a gene called RUNX1 might help doctors predict when patients with pulmonary arterial hypertension (PAH) — a serious lung disease that makes it hard to pump blood — could develop heart problems. When the right side of the heart weakens in PAH patients, it becomes very dangerous. This discovery could help doctors catch and treat these heart problems earlier.
WHY IT MATTERSIf RUNX1 becomes a validated biomarker, PAH patients could receive earlier interventions to prevent right heart failure, potentially improving survival and quality of life before irreversible damage occurs.
NewsRSS2 days ago
This article shares a personal story about someone who was a caregiver for their uncle who had Parkinson's disease. The piece focuses on the emotional and physical challenges of being a caregiver for a family member with this progressive neurological condition. It highlights how caregiving can be a heavy burden, both emotionally and practically.
WHY IT MATTERSParkinson's caregivers often experience significant emotional strain and isolation—this story validates those experiences and may help caregivers feel less alone in their struggles.
Clinical trialRSS2 days ago
A company called BlueRock Therapeutics tested a new cell therapy called bemdaneprocel for Parkinson's disease. In a small early-stage trial, patients who received one dose of this therapy showed improvement in their movement symptoms, and these improvements lasted for up to three years. This is promising because it suggests a single treatment might help Parkinson's patients for a long time.
WHY IT MATTERSIf bemdaneprocel continues to show sustained benefits in larger trials, it could offer Parkinson's patients a one-time treatment option instead of daily medications, potentially improving quality of life and treatment adherence.
NewsRSS2 days ago
A patient with LGMD (a rare muscle disease) received a tracheostomy — a breathing tube in the neck — years ago after a serious infection. Now they're wondering if it's time to have it removed. This personal story explores what it takes to reverse this medical decision.
WHY IT MATTERSFor LGMD patients managing respiratory complications, this firsthand account addresses a critical quality-of-life decision about whether a tracheostomy can be safely removed as the patient's condition changes.
NewsRSS2 days ago
This article invites people to take a quiz about the history of SM (Systemic Mastocytosis) and compare their answers with other people who took the quiz. It's a fun way to test what you know about this rare disease and learn more about it.
WHY IT MATTERSUnderstanding the history and background of systemic mastocytosis can help patients better understand their diagnosis and feel more connected to the broader SM community.
AdvocacyRSS2 days ago
Children with Prader-Willi Syndrome (PWS) have real character strengths and positive qualities, but the challenges of the condition can make these strengths difficult for families to notice and support. Recognizing these strengths is important for family wellbeing. However, even when caregivers understand their child's strengths, actually supporting them can be exhausting for parents and guardians who are already managing the demands of PWS.
WHY IT MATTERSFor families managing PWS, understanding that their child has genuine strengths—beyond the condition's challenges—can improve how they view their child and their own emotional wellbeing, even though caregiving remains demanding.
AdvocacyRSS2 days ago
Bruce Campbell, who has Pompe disease, is competing in the Absa Cape Epic, one of the world's toughest mountain biking races. Despite living with a rare muscle disease that affects his strength and endurance, he decided to take on this extreme athletic challenge. His story shows how people with rare diseases can push their limits and achieve goals they set for themselves.
WHY IT MATTERSThis story demonstrates that people living with Pompe disease can maintain active lifestyles and pursue challenging physical goals, which may inspire patients to discuss realistic exercise options with their care team.
NewsRSS2 days ago
A person with ITP (a blood disorder where the body doesn't make enough platelets) asked their family and close friends what was hardest about their illness. Their honest answers showed how much their loved ones care and how strong their relationships really are. The article explores how having a chronic illness affects not just the patient, but everyone close to them.
WHY IT MATTERSUnderstanding how ITP impacts relationships helps patients and caregivers recognize that emotional support from loved ones is a critical part of managing a chronic illness, not just medical treatment.
NewsRSS2 days ago
This article is a quiz that tests your knowledge about what causes FSGS, a rare kidney disease. FSGS stands for focal segmental glomerulosclerosis, which means parts of the kidney's filtering units become scarred and stop working properly. Taking this quiz can help you learn more about the different reasons someone might develop this condition.
WHY IT MATTERSUnderstanding the different causes of FSGS is important because the underlying cause affects which treatments your doctor might recommend and how your condition may progress.
NewsRSS2 days ago
A patient with AATD (Alpha-1 Antitrypsin Deficiency) found personal inspiration by watching the movie Top Gun: Maverick, discovering parallels between the fighter pilot's perseverance and their own journey managing a chronic lung disease. The article explores how popular culture can provide emotional support and motivation for people living with rare diseases. This is a personal reflection piece rather than medical news.
WHY IT MATTERSFor AATD patients, finding relatable stories and sources of inspiration in everyday media can help combat the isolation and emotional burden of managing a progressive genetic lung disease.
AdvocacyRSS2 days ago
A patient with MS shares their personal experience of why starting treatment quickly with the most powerful available medications is worth it to them. They believe the benefits of aggressive, early treatment outweigh the potential side effects. This is one patient's perspective on MS treatment strategy.
WHY IT MATTERSThis patient perspective highlights the real-world decision-making that people with MS face when choosing between starting strong treatments early versus waiting, which can help other newly diagnosed patients think through their own treatment conversations.
NewsRSS2 days ago
This article is a quiz about nerandomilast, a medicine being studied to treat progressive pulmonary fibrosis (PPF), which is a lung disease where lung tissue becomes scarred and stiff over time, making it harder to breathe. The quiz helps patients and caregivers learn more about this potential treatment option. It's a way to test your understanding of how this medicine might help people with this serious lung condition.
WHY IT MATTERSPatients with progressive pulmonary fibrosis have limited treatment options, so learning about emerging therapies like nerandomilast helps them stay informed about potential new ways to slow lung damage.
NewsRSS2 days ago
A patient shares their experience with neuromyelitis optica spectrum disorder (NMOSD), a rare disease that affects the nerves in the spinal cord and eyes. They describe how they initially ignored their first symptom until it became so severe that both they and their doctor couldn't overlook it anymore. This personal story highlights how NMOSD symptoms can start small but need prompt medical attention.
WHY IT MATTERSUnderstanding early warning signs of NMOSD is critical because delayed diagnosis can lead to permanent nerve damage, and patients who recognize symptoms sooner may have better outcomes with early treatment.